{"id":"https://openalex.org/W2091851204","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1551","title":"Molecular Pathways: CDK4 Inhibitors for Cancer Therapy","display_name":"Molecular Pathways: CDK4 Inhibitors for Cancer Therapy","alternate_titles":[],"publication_year":2014,"publication_date":"2014-06-30","ids":{"openalex":"https://openalex.org/W2091851204","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1551","mag":"2091851204","pmid":"https://pubmed.ncbi.nlm.nih.gov/24795392"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-13-1551","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1551","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-1551","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2091851204"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043833554","display_name":"Mark Andrew Dickson","orcid":"https://orcid.org/0000-0003-2764-751X","observed_orcids":["https://orcid.org/0000-0003-2764-751X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mark A. Dickson","raw_affiliation_strings":["Author's Affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Author's Affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043833554"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4387153466"],"apc_list":null,"apc_paid":null,"fwci":4.3366,"has_fulltext":false,"cited_by_count":271,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97462687,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"20","issue":"13","first_page":"3379","last_page":"3383"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.6470000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.3212999999523163,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.016200000420212746,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk4-inhibitors","display_name":"CDK4 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/cdk4","display_name":"CDK4","score":0.847000002861023},{"id":"https://openalex.org/keywords/g1-s-transition","display_name":"G1/S transition","score":0.7549999952316284},{"id":"https://openalex.org/keywords/rb-phosphorylation","display_name":"retinoblastoma protein phosphorylation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/p16","display_name":"p16","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cyclin-d","display_name":"cyclin D","score":0.9629999995231628},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.996999979019165},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.984000027179718},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8090000152587891},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-resistance-mechanisms","display_name":"drug resistance mechanisms","score":0.7919999957084656},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9098395109176636},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.7187381982803345},{"id":"https://openalex.org/C199649820","wikidata":"https://www.wikidata.org/wiki/Q14911762","display_name":"Cyclin-dependent kinase 6","level":5,"score":0.6333541870117188},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6159301400184631},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6019587516784668},{"id":"https://openalex.org/C2776577112","wikidata":"https://www.wikidata.org/wiki/Q500695","display_name":"Retinoblastoma","level":3,"score":0.5458878874778748},{"id":"https://openalex.org/C2776062698","wikidata":"https://www.wikidata.org/wiki/Q21111463","display_name":"Retinoblastoma protein","level":4,"score":0.5274415612220764},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.5046497583389282},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5002231597900391},{"id":"https://openalex.org/C11882975","wikidata":"https://www.wikidata.org/wiki/Q24781041","display_name":"Cyclin D","level":5,"score":0.41298601031303406},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37121856212615967},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.343866765499115},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.31461024284362793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2394910752773285},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.18719422817230225},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.12489360570907593},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07369652390480042},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012106","descriptor_name":"Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051358","descriptor_name":"Cyclin-Dependent Kinase 4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051358","descriptor_name":"Cyclin-Dependent Kinase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D056741","descriptor_name":"Cyclin D","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-13-1551","doi":"https://doi.org/10.1158/1078-0432.ccr-13-1551","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-1551","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:24795392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24795392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1985389450","https://openalex.org/W2004000621","https://openalex.org/W2007112340","https://openalex.org/W2007158936","https://openalex.org/W2017898416","https://openalex.org/W2018685544","https://openalex.org/W2020099088","https://openalex.org/W2030070078","https://openalex.org/W2035201281","https://openalex.org/W2038616177","https://openalex.org/W2041468663","https://openalex.org/W2044348066","https://openalex.org/W2045059362","https://openalex.org/W2046024621","https://openalex.org/W2049804579","https://openalex.org/W2051506850","https://openalex.org/W2055685217","https://openalex.org/W2059195185","https://openalex.org/W2069832975","https://openalex.org/W2075066807","https://openalex.org/W2077611283","https://openalex.org/W2086797990","https://openalex.org/W2106198179","https://openalex.org/W2107480474","https://openalex.org/W2117987173","https://openalex.org/W2128560398","https://openalex.org/W2131017274","https://openalex.org/W2132141505","https://openalex.org/W2132726386","https://openalex.org/W2136158663","https://openalex.org/W2144241792","https://openalex.org/W2145657367","https://openalex.org/W2148345265","https://openalex.org/W2154626333","https://openalex.org/W2241071205","https://openalex.org/W2523982432","https://openalex.org/W3011926296"],"related_works":["https://openalex.org/W2096979580","https://openalex.org/W2219817965","https://openalex.org/W4211142022","https://openalex.org/W2610208039","https://openalex.org/W2621171915","https://openalex.org/W2583136106","https://openalex.org/W2043761487","https://openalex.org/W2318725321","https://openalex.org/W2404490516","https://openalex.org/W2297912447"],"abstract_inverted_index":{"Unrestrained":[0],"growth":[1],"is":[2,15,45],"the":[3,16,20,48,79,87,93],"hallmark":[4],"of":[5,19,50,82,122,147,152,158],"cancer,":[6,133],"and":[7,33,52,75,110,124,136,154,163],"disrupted":[8],"cell-cycle":[9,35],"regulation":[10],"is,":[11,53],"therefore,":[12],"common.":[13],"CDK4":[14,28,65,84,101,112,159],"key":[17],"regulator":[18],"G1-S":[21],"transition.":[22],"In":[23],"complex":[24],"with":[25,66,161],"cyclin":[26],"D,":[27],"phosphorylates":[29],"retinoblastoma":[30],"protein":[31],"(Rb)":[32],"drives":[34],"progression,":[36],"a":[37,55,119],"process":[38],"inhibited":[39],"by":[40],"p16.":[41],"The":[42],"p16-CDK4-cyclin":[43],"D-Rb":[44],"aberrant":[46],"in":[47,115,125,131],"majority":[49],"cancers":[51,123],"thus,":[54],"logical":[56],"target":[57,92],"for":[58,95],"anticancer":[59],"therapy.":[60,97],"Previous":[61],"attempts":[62],"to":[63,73,91,144],"block":[64],"nonselective":[67],"cyclin-dependent":[68],"kinase":[69],"(CDK)":[70],"inhibitors":[71,85,102,113,160],"led":[72],"toxicity":[74],"little":[76],"efficacy.":[77],"However,":[78],"recent":[80],"development":[81],"selective":[83,100],"launched":[86],"first":[88],"successful":[89],"efforts":[90,140],"pathway":[94],"cancer":[96],"Three":[98],"oral":[99],"have":[103,114,127],"entered":[104],"clinical":[105],"trials:":[106],"palbociclib":[107],"(PD0332991),":[108],"LEE011,":[109],"LY2835219.":[111],"vitro":[116],"activity":[117,130],"against":[118],"broad":[120],"range":[121],"patients":[126],"shown":[128],"antitumor":[129],"breast":[132],"lymphoma,":[134],"sarcoma,":[135],"other":[137,164],"tumors.":[138],"Major":[139],"are":[141],"under":[142],"way":[143],"develop":[145,155],"biomarkers":[146],"response,":[148],"understand":[149],"potential":[150],"mechanisms":[151],"resistance,":[153],"rational":[156],"combinations":[157],"chemotherapy":[162],"targeted":[165],"drugs.":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2091851204","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":27},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":29},{"year":2016,"cited_by_count":31},{"year":2015,"cited_by_count":42},{"year":2014,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
